Resources Contact Us Home
Assay for methylation in the GST-Pi gene

Image Number 10 for United States Patent #8088577.

A diagnostic or prognostic assay is disclosed for a disease of condition characterized by abnormal methylation of cytosine at side or sites within the glutathione-S-transferase (GST) Pi gene and/or its regulatory flanking sequences (e.g., prostate cancer and liver cancer). The assay comprises: (i) isolating DNA from said subject, and (ii) determining (e.g., by selective PCR amplification) the presence of abnormal methylation of cytosine at a site or sites within the GST-Pi gene and/or its regulatory flanking sequences.

  Recently Added Patents
Electronic document reading devices
Methods and arrangements for realising betting with off-line terminal
Obviation of recovery of data store consistency for application I/O errors
Testing SQL query writing skills
Artifact removal in nuclear images
Glow in the dark swim goggle frame and band
Method and apparatus for supporting delivery, sale and billing of perishable and time-sensitive goods such as newspapers, periodicals and direct marketing and promotional materials
  Randomly Featured Patents
Process for polymerizing alpha-olefins with trimethylaluminum-activated catalyst
Galanthamine derivatives as acetylcholinesterase inhibitors
Flexible pedal
Antenna having reversibly retained torque wrench intended to assist in tightening the antenna
Multilayer coil component and method for manufacturing the same
Drinking straw with a heron shape
MR imaging method and apparatus
Graphics subsystem with coarse subpixel correction
Polyketone copolymers of high bulk density and non-reactivity
Housing for battery-operated device